Palisade Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-67,756
| Closed | -$3.43M | – | 510 |
|
|
2016
Q3 | $3.43M | Sell |
67,756
-20,882
| -24% | -$1.06M | 0.12% | 225 |
|
|
2016
Q2 | $4.03M | Sell |
88,638
-56,524
| -39% | -$2.57M | 0.15% | 203 |
|
|
2016
Q1 | $5.74M | Sell |
145,162
-61,455
| -30% | -$2.43M | 0.19% | 171 |
|
|
2015
Q4 | $11.7M | Sell |
206,617
-30,041
| -13% | -$1.7M | 0.38% | 78 |
|
|
2015
Q3 | $9.42M | Buy |
236,658
+101,804
| +75% | +$4.05M | 0.28% | 130 |
|
|
2015
Q2 | $6.44M | Buy |
+134,854
| New | +$6.44M | 0.16% | 216 |
|